| Variables | Variable | Effective n (%) |
|
|
| CRP | Neg | 25 (16.7) |
|
|
| 15 - 100 | 104 (69.3) |
|
| |
| >100 | 21 (14) |
|
| |
| Aspect CSF | Cloudy | 55 (36.7) |
|
|
| Clair | 95 (65.3) |
|
| |
| Pleocytose | <10 | 90 (60) |
|
|
| 10 - 99 | 23 (15.3) |
|
| |
| ≥100 | 37 (24.7) |
|
| |
| Hospitalisation duration | 1 à 3 days | 37 (24.7) |
|
|
| 4 à 10 days | 60 (40) |
|
| |
| 11 à 20 days | 37 (24.7) |
|
| |
| ≥21 days | 16 (10.6) |
|
| |
| Identified pathogens | Bacteria | 25 (16.7) |
|
|
| Virus | 9 (6) |
|
| |
| Coinfection virus-bacteria | 3 (2) |
|
| |
| Aseptic | 113 (75.3) |
|
| |
|
|
|
| CRP ≥ 20 mg/dl | GB ≥ 10,000 |
| RT/PCR of CSF | Haemophilus Influenzae (n = 6) | 14 (9.3) | 6 (100) | 6 (100) |
| Streptococcus Pneumoniae (n = 14) | 6 (4) | 14 (100) | 14 (100) | |
| Streptococcus agalactiae (n = 5) | 5 (3.3) | 5 (100) | 5 (100) | |
| CMV (n = 5) | 5 (3.3) | 4 (80) | 5 (100) | |
| Herpes Virus (n = 4) | 4 (2.7) | 3 (75) | 3 (75) | |
| CMV+ Pneumococcus pneumoniae (n = 3) | 3 (2) | 3 (100) | 3 (100) | |
| Aseptic (n = 113) | 113 (75.3) | 81 (71.7) | 89 (78.8) |